CVS
CVS Health Corporation (CVS)
Last Price$64.9(1.2%)
Market Cap$82.3B
LTM Free Cash Flow
$6,326.0M
Reverse DCF (Implied FCF growth)
(27.9%)
3Y Free Cash Flow CAGR
(26.2%)
LTM Revenue
$372.8B
Reverse DCF (Implied Revenue growth)
(24.5%)
at normalized FCF margin 1.2%
3Y Revenue CAGR
8.5%

CVS Reverse DCF Model

Implied FCF growth
Implied Revenue growth

Reverse DCF Assumptions and Outputs

as of Dec 31, 2024
Long-Term growth rate
3.0%
FX rate
1.0
Last share price
44.9
Implied FCF growth 1-10Y
(27.9%)

Implied Free Cash Flow growth vs Historical average vs Industry growth

Best stock ideas on the market right now

With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.

CVS Free Cash Flow

Annual
Quarterly
LTM
0.05,000.0M10.0B15.0BDec'06Dec'08Dec'10Dec'12Dec'14Dec'16Dec'18Dec'20Dec'22Dec'24

CVS Growth

Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
Crunching data... Almost there!
Crunching data... Almost there!

CVS vs Peer Set: Reverse DCF comparison

Explore more intrinsic value tools hub for CVS

FAQ

What is CVS Health Corporation Reverse DCF (discounted cash flow) valuation?

As of Dec 31, 2024, CVS Health Corporation's Reverse Discounted Cash Flow (DCF) valuation estimates its Free Cash Flow growth at (27.9%).

What is CVS Health Corporation WACC?

As of Dec 31, 2024, CVS Health Corporation's Weighted Average Cost of Capital (WACC) is approximately 3.5%.

What is CVS Health Corporation Free Cash Flow?

As of Dec 31, 2024, CVS Health Corporation's Free Cash Flow is $6,326.0M.